A Study Comparing CoQ10 Levels While Taking 3 Different Statins

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

Also called NCT01660191

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 134 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01660191
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01660191. Randomized; double masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2017-01-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
Acronym
SPARQ
Condition
Hypercholesterolemia
Intervention (Drug)
Pitavastin 4mg
Intervention (Drug)
Atorvastatin 20mg
Intervention (Drug)
Rosuvastatin 5mg
Lead sponsor
University of Kansas Medical Center (class: other)
Collaborator
Kowa Pharmaceuticals America, Inc. (class: industry)
Collaborator
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01660191
Content hash
f9cd3b31b0b7ee73bbf15e86aac45c6c398391599a5087c27d3f9052ea3e51de